Evidence map›Paper›PMID 28100229›Full record

ArticleAnnals of clinical microbiology and antimicrobials2017

Surveillance of life-long antibiotics: a review of antibiotic prescribing practices in an Australian Healthcare Network.

Jillian S Y Lau, Christopher Kiss, Erika Roberts, Kylie Horne, Tony M Korman, Ian Woolley

Open access · goldAbstract read
In one paragraph

Article in Annals of clinical microbiology and antimicrobials, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. The Use of Long-term Antibiotics for Suppression of Bacterial Infections.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Review
  3. OralPathogens (Basel, Switzerland) · 2024
    Article
  4. Article
  5. Article
  6. Review
  7. Antimicrobial Resistance in the Context of the Sustainable Development Goals: A Brief Review.European journal of investigation in health, psychology and education · 2021
    Article
  8. Review
  9. Infectious diseases physician attitudes to long-term antibiotic use.International journal of clinical pharmacy · 2019
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jillian S Y LauMonash Infectious Diseases, Monash University, Monash Health, Clayton, VIC, Australia.
Christopher KissMonash Infectious Diseases, Monash University, Monash Health, Clayton, VIC, Australia.
Erika RobertsMonash Health Pharmacy, Monash Health, Clayton, VIC, Australia.
Kylie HorneMonash Infectious Diseases, Monash University, Monash Health, Clayton, VIC, Australia.
Tony M KormanMonash Infectious Diseases, Monash University, Monash Health, Clayton, VIC, Australia.
Ian WoolleyMonash Infectious Diseases, Monash University, Monash Health, Clayton, VIC, Australia. ian.woolley@monash.edu.ORCID http://orcid.org/0000-0003-2928-1291
Monash Health · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe rise of antimicrobial use in the twentieth century has significantly reduced morbidity due to infection, however it has also brought with it the rise of increasing resistance. Some patients are on prolonged, if not "life-long" course of antibiotics. The reasons for this are varied, and include non-infectious indications. We aimed to study the characteristics of this potential source of antibiotic resistance, by exploring the antibiotic dispensing practices and describing the population of patients on long-term antibiotic therapy.

methodsA retrospective cross-sectional study of antibiotic dispensing records was performed at a large university hospital-based healthcare network in Melbourne, Australia. Outpatient prescriptions were extracted from the hospital pharmacy database over a 6 month period in 2014. Medical records of these patients were reviewed to determine the indication for prescription, including microbiology, the intended duration, and the prescribing unit. A descriptive analysis was performed on this data.

results66,127 dispensing episodes were reviewed. 202 patients were found to have been prescribed 1 or more antibiotics with an intended duration of 1 year or longer. 69/202 (34%) of these patients were prescribed prolonged antibiotics for primary prophylaxis in the setting of immunosuppression. 43/202 (21%) patients were prescribed long-term suppressive antibiotics for infections of thought incurable (e.g. vascular graft infections), and 34/43 (79%) were prescribed by Infectious Diseases doctors. 66/202 (33%) patients with cystic fibrosis were prescribed prolonged courses of macrolides or fluoroquinolones, by respiratory physicians. There was great heterogeneity noted in indications for prolonged antibiotic courses, as well as antibiotic agents utilised.

conclusionOur study found that that continuous antibiotic therapy represented only a small proportion of overall antibiotic prescribing at our health network. Prolonged courses of antibiotics were used mainly to suppress infections thought incurable, but also as primary and secondary prophylaxis and as anti-inflammatory agents. More research is needed to understand the impact of long-term antibiotic consumption on both patients and microbial ecology.

Indexed as

Immunocompromised HostAdolescentAdultAgedAged, 80 and overAnti-Bacterial AgentsAustraliaBacterial InfectionsChildChild, PreschoolCross-Sectional StudiesDelivery of Health CareDrug PrescriptionsDrug UtilizationFemaleFluoroquinolonesAnti-Bacterial AgentsFluoroquinolonesMacrolidesAntibioticsInfectionPharmacyResistanceSuppression

Identifiers

PMID28100229
PMCPMC5241934
OpenAlexW2578606329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.